Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bryan

Showing results (421-430 of 562) with videos related to

Pageof 57
Sort By:
Vaccine|August 4, 2009
Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccineAli Rowhani-Rahbar, Constance Mao, James P Hughes, et al.
BJU International|May 12, 2019
Health-related quality of life around the time of diagnosis in patients with bladder cancerEvan Yi-Wen Yu, Duncan Nekeman, Lucinda J Billingham, et al.
Future Oncology (London, England)|February 17, 2016
The PD-1/PD-L1 axis in the pathogenesis of urothelial bladder cancer and evaluating its potential as a therapeutic targetAntonio D Bardoli, Mehran Afshar, Richard Viney, et al.
Pilot and Feasibility Studies|December 9, 2020
Development and validation of a follow-up methodology for a randomised controlled trial, utilising routine clinical data as an alternative to traditional designs: a pilot study to assess the feasibility of use for the BladderPath trialHarriet P Mintz, Amandeep Dosanjh, Helen M Parsons, et al.
Bladder Cancer (Amsterdam, Netherlands)|February 13, 2018
Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the <i>TERT</i> 228 G>A/T MutationIlaria J Russo, Yongwon Ju, Naheema S Gordon, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1993
Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-betaP L Witt, B E Storer, G T Bryan, et al.
European Urology|May 11, 2021
Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?Richard T Bryan, James W F Catto, Kieran P Jefferson, et al.
The American Journal of Tropical Medicine and Hygiene|March 11, 1992
Alterations in filarial antigen-specific immunologic reactivity following treatment with ivermectin and diethylcarbamazineP J Lammie, A W Hightower, F O Richards, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 1999
Hantavirus pulmonary syndrome in pregnancyM J Howard, T J Doyle, F T Koster, et al.
Urology|July 19, 2024
Low-grade Urothelial Carcinoma Recurs at a Tempo that Naturally Accelerates Over TimeAlex Sankin, Priya Dave, Louise-Rae Cherrill, et al.
Pageof 57

Showing results (421-430 of 562) with videos related to

Sort By:
Pageof 57
Vaccine|August 4, 2009
Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccineAli Rowhani-Rahbar, Constance Mao, James P Hughes, et al.
BJU International|May 12, 2019
Health-related quality of life around the time of diagnosis in patients with bladder cancerEvan Yi-Wen Yu, Duncan Nekeman, Lucinda J Billingham, et al.
Future Oncology (London, England)|February 17, 2016
The PD-1/PD-L1 axis in the pathogenesis of urothelial bladder cancer and evaluating its potential as a therapeutic targetAntonio D Bardoli, Mehran Afshar, Richard Viney, et al.
Pilot and Feasibility Studies|December 9, 2020
Development and validation of a follow-up methodology for a randomised controlled trial, utilising routine clinical data as an alternative to traditional designs: a pilot study to assess the feasibility of use for the BladderPath trialHarriet P Mintz, Amandeep Dosanjh, Helen M Parsons, et al.
Bladder Cancer (Amsterdam, Netherlands)|February 13, 2018
Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the <i>TERT</i> 228 G>A/T MutationIlaria J Russo, Yongwon Ju, Naheema S Gordon, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1993
Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-betaP L Witt, B E Storer, G T Bryan, et al.
European Urology|May 11, 2021
Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer?Richard T Bryan, James W F Catto, Kieran P Jefferson, et al.
The American Journal of Tropical Medicine and Hygiene|March 11, 1992
Alterations in filarial antigen-specific immunologic reactivity following treatment with ivermectin and diethylcarbamazineP J Lammie, A W Hightower, F O Richards, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 1999
Hantavirus pulmonary syndrome in pregnancyM J Howard, T J Doyle, F T Koster, et al.
Urology|July 19, 2024
Low-grade Urothelial Carcinoma Recurs at a Tempo that Naturally Accelerates Over TimeAlex Sankin, Priya Dave, Louise-Rae Cherrill, et al.
Pageof 57